Calton & Associates »

Allogene Therapeutics shares owned by Calton & Associates

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Calton & Associates from 13F filings

Historical chart of Calton & Associates investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Calton & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Calton & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $68k 21k 3.21
2023-06-30 $114k 23k 4.97
2023-03-31 $117k 24k 4.94
2022-12-31 $103k 16k 6.29
2022-09-30 $123k 12k 10.73
2022-06-30 $197k 17k 11.35
2022-03-31 $166k 18k 9.06
2021-09-30 $245k 9.5k 25.67
2021-03-31 $214k 6.1k 35.27